Ingmar Bruns - Insider Trading & Ownership

Entity
Individual
Location
C/O Trillium Therapeutics Inc., 2488 Dunwin Drive, Mississauga, Ontario, Canada
All Insider Reports
All Insider Reports

Ownership of Ingmar Bruns

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TRIL Trillium Therapeutics Inc. Chief Medical Officer Nov 17, 2021
ZNTL Zentalis Pharmaceuticals, Inc. Chief Medical Officer Dec 2, 2024

Insider Transactions Reported by Ingmar Bruns:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.